Drupal.behaviors.print = function(context) {window.print();window.close();}>
Power3 Inks Parkinson's Protein Biomarker Deal with Amarantus, Looks to Enter CRO Space
January 30, 2012
Power3 Inks Parkinson's Protein Biomarker Deal with Amarantus, Looks to Enter CRO Space
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Amarantus Buys Power3's IP Portfolio for $40K
December 26, 2012 / GenomeWeb Daily News
BU Team IDs RNA-Binding Proteins as Potential Alzheimer's Biomarkers
June 22, 2012 / ProteoMonitor
Durin Tech Expands Antibody-Array Dx Efforts to Parkinson's, Shows High Accuracy
March 9, 2012 / ProteoMonitor
Amarantus Licenses Power3 Test for Parkinson's Disease
January 23, 2012 / GenomeWeb Daily News
Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor